EP0779813A4 - Phosphonates and parathyroid hormone for osteoporosis - Google Patents

Phosphonates and parathyroid hormone for osteoporosis

Info

Publication number: EP0779813A4
Authority: EP; European Patent Office
Prior art keywords: phosphonates; osteoporosis; parathyroid hormone; parathyroid; hormone
Prior art date: 1994-09-09
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP95933745A

Other languages

German (de)

French (fr)

Other versions

EP0779813A1 (en

Inventor

Ann Dunbar Geddes

John Althorp Bevan

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Procter and Gamble Co

Original Assignee

Procter and Gamble Co

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-09-09

Filing date

1995-09-06

Publication date

1998-05-06

1995-09-06 Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co

1997-06-25 Publication of EP0779813A1 publication Critical patent/EP0779813A1/en

1998-05-06 Publication of EP0779813A4 publication Critical patent/EP0779813A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/29—Parathyroid hormone, i.e. parathormone; Parathyroid hormone-related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A61P5/12—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH for decreasing, blocking or antagonising the activity of the posterior pituitary hormones

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Endocrinology (AREA)
Epidemiology (AREA)
Physical Education & Sports Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Diabetes (AREA)
Obesity (AREA)
Hematology (AREA)
Nutrition Science (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

EP95933745A 1994-09-09 1995-09-06 Phosphonates and parathyroid hormone for osteoporosis Withdrawn EP0779813A4 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US30398194A	1994-09-09	1994-09-09
US303981		1994-09-09
PCT/US1995/011336 WO1996007418A1 (en)	1994-09-09	1995-09-06	Phosphonates and parathyroid hormone for osteoporosis

Publications (2)

Publication Number	Publication Date
EP0779813A1 EP0779813A1 (en)	1997-06-25
EP0779813A4 true EP0779813A4 (en)	1998-05-06

Family

ID=23174525

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP95933745A Withdrawn EP0779813A4 (en)	1994-09-09	1995-09-06	Phosphonates and parathyroid hormone for osteoporosis

Country Status (9)

Country	Link
EP (1)	EP0779813A4 (en)
JP (1)	JPH10505091A (en)
KR (1)	KR970705399A (en)
CN (1)	CN1157566A (en)
AU (1)	AU686019B2 (en)
CA (1)	CA2199251A1 (en)
IL (1)	IL115223A0 (en)
PE (1)	PE48597A1 (en)
WO (1)	WO1996007418A1 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5616571A (en) *	1995-06-06	1997-04-01	Merck & Co., Inc.	Bisphosphonates prevent bone loss associated with immunosuppressive therapy
HN1996000101A (en) *	1996-02-28	1997-06-26	Inc Pfizer	COMBINED THERAPY FOR OSTEOPOROSIS
ATE304856T1 (en)	2000-06-20	2005-10-15	Novartis Pharma Gmbh	METHOD OF ADMINISTRATION OF BIPHOSPHONATES
ATE353656T1 (en) *	2000-10-27	2007-03-15	Schering Ag	BISPHOSPHONIC ACID DERIVATIVES FOR STRENGTHENING CORTICAL BONE
WO2007059470A2 (en)	2005-11-10	2007-05-24	Board Of Control Of Michigan Technological University	Black bear parathyroid hormone and methods of using black bear parathyroid hormone
AU2009356227A1 (en)	2009-12-07	2012-06-21	Michigan Technological University	Black bear parathyroid hormone and methods of using black bear parathyroid hormone

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0514720A2 (en) *	1991-05-03	1992-11-25	Celtrix Pharmaceuticals, Inc.	Bone growth factors and inhibitors of bone resorption for promoting bone formation
WO1993011786A1 (en) *	1991-12-17	1993-06-24	Procter & Gamble Pharmaceuticals, Inc.	Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone

1995
- 1995-09-06 CA CA002199251A patent/CA2199251A1/en not_active Abandoned
- 1995-09-06 KR KR1019970701531A patent/KR970705399A/en not_active Application Discontinuation
- 1995-09-06 EP EP95933745A patent/EP0779813A4/en not_active Withdrawn
- 1995-09-06 CN CN95195087A patent/CN1157566A/en active Pending
- 1995-09-06 JP JP8509665A patent/JPH10505091A/en active Pending
- 1995-09-06 AU AU36277/95A patent/AU686019B2/en not_active Ceased
- 1995-09-06 WO PCT/US1995/011336 patent/WO1996007418A1/en not_active Application Discontinuation
- 1995-09-08 IL IL11522395A patent/IL115223A0/en unknown
1996
- 1996-03-12 PE PE1996000165A patent/PE48597A1/en not_active Application Discontinuation

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP0514720A2 (en) *	1991-05-03	1992-11-25	Celtrix Pharmaceuticals, Inc.	Bone growth factors and inhibitors of bone resorption for promoting bone formation
WO1993011786A1 (en) *	1991-12-17	1993-06-24	Procter & Gamble Pharmaceuticals, Inc.	Methods for the treatment of osteoporosis using bisphosphonates and parathyroid hormone

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO9607418A1 *

Also Published As

Publication number	Publication date
PE48597A1 (en)	1997-12-11
JPH10505091A (en)	1998-05-19
IL115223A0 (en)	1995-12-31
EP0779813A1 (en)	1997-06-25
WO1996007418A1 (en)	1996-03-14
CA2199251A1 (en)	1996-03-14
AU3627795A (en)	1996-03-27
KR970705399A (en)	1997-10-09
CN1157566A (en)	1997-08-20
AU686019B2 (en)	1998-01-29

Publication	Publication Date	Title
LT99010A (en)	1999-12-27	Parathyroid hormone analogues for the treatment of osteoporosis
IL112455A0 (en)	1995-03-30	Combination treatment for osteoporosis
ZA984077B (en)	1998-11-24	Peptide parathyroid hormone analogs
ZA929758B (en)	1993-09-10	Methods for the treatment of osteoporosis using biphosphonates and parathyroid hormone
HUP9901718A3 (en)	2000-10-30	Analogs of parathyroid hormone
HK1018210A1 (en)	1999-12-17	Combination therapy for osteoporosis
HUP9904596A3 (en)	2000-07-28	Analogs of parathyroid hormone
IL115529A0 (en)	1996-01-19	Benzo-fused compounds
IL127781A0 (en)	1999-10-28	Steroid bisphosphonates
GB9414909D0 (en)	1994-09-14	Osteoporosis apparatus
IL117907A0 (en)	1996-08-04	Truncated IGF-I
EP0656784A4 (en)	1997-06-04	Parathyroid hormone fragments and analogs.
EP0779813A4 (en)	1998-05-06	Phosphonates and parathyroid hormone for osteoporosis
GB9518611D0 (en)	1995-11-15	Anti-apoptotic factors
EP0779812A4 (en)	1997-09-10	Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
GB2309083B (en)	1998-02-18	Osteoporosis apparatus
GB9422192D0 (en)	1994-12-21	Apparatus for forming malleable material
ZA961860B (en)	1996-10-08	Method for the treatment of osteoporosis using estrogen compounds and parathyroid hormone
GB9615350D0 (en)	1996-09-04	Hormone replacement therapy
IL110183A0 (en)	1994-10-21	Osteoporosis prevention apparatus
GB9513495D0 (en)	1995-09-06	Material remover
ZA9861B (en)	1998-07-07	Analogs of parathyroid hormone
GB9406641D0 (en)	1994-06-08	Image intensifier
ZA961859B (en)	1996-10-08	Methods for the treatment of osteoporosis using bone active phosphonates and parathyroid hormone
GB9410970D0 (en)	1994-07-20	Bit-focussed multiplier

Legal Events

Date	Code	Title	Description
1997-05-09	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
1997-06-25	17P	Request for examination filed	Effective date: 19970403
1997-06-25	AK	Designated contracting states	Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
1998-04-29	RHK1	Main classification (correction)	Ipc: A61K 38/29
1998-05-06	A4	Supplementary search report drawn up and despatched	Effective date: 19980319
1998-05-06	AK	Designated contracting states	Kind code of ref document: A4 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LI LU NL PT SE
1999-12-08	17Q	First examination report despatched	Effective date: 19991020
2000-06-30	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2000-08-16	18D	Application deemed to be withdrawn	Effective date: 20000301